Comparison results
Results: Differences Similar | ✘Perforation of the uterus | ✘Spastic dysmenorrhea | ||||||||||
Related research | Analogs | Analogs | ||||||||||
| ||||||||||||
Distinctive symptoms | ||||||||||||
Register, to see more distinctive signs of diseases and studies | 100% | — | ||||||||||
Register, to see more distinctive signs of diseases and studies | — | 100% | ||||||||||
damage to the uterus | 47% | — | ||||||||||
monthly painful | — | 69% | ||||||||||
ascherman syndrome | 47% | — | ||||||||||
primary dysmenorrhea | — | 66% | ||||||||||
impaired uterine function | 43% | — | ||||||||||
painful menstruation the first day | — | 49% | ||||||||||
hematoma | 43% | — | ||||||||||
weakness before menstruation | — | 49% | ||||||||||
vaginal | 40% | — | ||||||||||
worse at beginning of your period | — | 46% | ||||||||||
cold in the stomach | 37% | — | ||||||||||
saddle uterus | — | 40% | ||||||||||
bending of the uterus | 37% | — | ||||||||||
weakness during menstruation | — | 38% | ||||||||||
endometrial cancer | 37% | — | ||||||||||
deterioration before menstruation | — | 34% | ||||||||||
soft tissue hematoma | 33% | — | ||||||||||
worse during menstruation | — | 33% | ||||||||||
bleeding into the abdominal cavity | 32% | — | ||||||||||
pain in the uterus | — | 31% | ||||||||||
bloody discharge from the vagina | 32% | — | ||||||||||
takes care of relatives | — | 30% | ||||||||||
control issues | 31% | — | ||||||||||
fainting | — | 25% | ||||||||||
cold sweat | 29% | — | ||||||||||
disorders of consciousness | — | 24% | ||||||||||
worse from cold | 28% | — | ||||||||||
nausea | — | 22% | ||||||||||
falls to the floor | 28% | — | ||||||||||
spasm | — | 22% | ||||||||||
worse from pressure | 26% | — | ||||||||||
quickly gets tired | — | 22% | ||||||||||
female pelvic organs | 50% | 22% | ||||||||||
bleeding | 21% | 21% | ||||||||||
ones indecision | 26% | — | ||||||||||
metastases | 24% | — | ||||||||||
sensitivity to medications | 22% | — | ||||||||||
cancer | 21% | — | ||||||||||
there are no complaints | 20% | — | ||||||||||
oncology | 20% | — |
Instructions
Video
|